Dr. reddy's laboratories announces the launch of albendazole tablets, usp in the u.s. market

Hyderabad, india & princeton, n.j.--(business wire)--dr. reddy's laboratories ltd. (bse: 500124, nse: drreddy, nyse: rdy, nseifsc: drreddy along with its subsidiaries together referred to as “dr. reddy's”) today announced the launch of albendazole tablets, usp, a therapeutic equivalent generic version of albenza tablets, 200 mg, approved by the u.s. food and drug administration (usfda). the albenza brand and generic had u.s. sales of approximately $27 million mat for the most recent twelve mont
RDY Ratings Summary
RDY Quant Ranking